Carna Biosciences Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	516.79	2,108	2,889	3,379	3,817
Cash & Short-Term Investments	516.79	2,108	2,889	3,379	3,817
Cash Growth	-75.48%	-27.03%	-14.50%	-11.47%	-11.21%
Receivables	100.53	87	788	182	1,243
Inventory	154.1	154	140	118	110
Prepaid Expenses	66.41	-	-	-	-
Other Current Assets	337.7	388	374	425	148
Total Current Assets	1,176	2,737	4,191	4,104	5,318
Property, Plant & Equipment	-	-	105	100	51
Long-Term Investments	54.12	34	51	59	59
Other Intangible Assets	-	-	1	1	2
Other Long-Term Assets	-	1	1	2	2
Total Assets	1,230	2,772	4,349	4,266	5,432
Accounts Payable	0.48	2	1	1	2
Current Portion of Long-Term Debt	8.41	19	120	151	239
Current Portion of Leases	8.49	8	6	-	-
Current Income Taxes Payable	2.08	180	218	265	332
Current Unearned Revenue	-	-	-	-	177
Other Current Liabilities	148.61	13	30	19	24
Total Current Liabilities	168.07	222	375	436	774
Long-Term Debt	681.25	8	28	148	300
Long-Term Leases	16.34	24	28	-	-
Other Long-Term Liabilities	54.77	44	42	42	45
Total Liabilities	920.43	298	473	626	1,119
Common Stock	14.85	2,447	2,076	1,382	1,056
Additional Paid-In Capital	2,197	6,198	5,827	5,133	4,808
Retained Earnings	-1,981	-6,253	-4,075	-2,922	-1,572
Treasury Stock	-0.23	-	-	-	-
Comprehensive Income & Other	78.56	82	48	47	21
Shareholders' Equity	309.22	2,474	3,876	3,640	4,313
Total Liabilities & Equity	1,230	2,772	4,349	4,266	5,432
Total Debt	714.49	59	182	299	539
Net Cash (Debt)	-197.7	2,049	2,707	3,080	3,278
Net Cash Growth	-	-24.31%	-12.11%	-6.04%	-15.32%
Net Cash Per Share	-10.34	114.41	161.13	226.18	258.20
Filing Date Shares Outstanding	19.14	19.1	17.14	16.34	13.48
Total Common Shares Outstanding	19.14	19.1	17.14	14.21	13.31
Working Capital	1,007	2,515	3,816	3,668	4,544
Book Value Per Share	16.16	129.55	226.07	256.14	324.08
Tangible Book Value	309.22	2,474	3,875	3,639	4,311
Tangible Book Value Per Share	16.16	129.55	226.02	256.07	323.93
Order Backlog	-	13.09	39.76	58.12	257.29

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.